v3.25.4
Share-Based Expense (Tables)
 12 Months Ended
Dec. 31, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of share-based compensation expense
        
   Year Ended December 31, 
   2025   2024 
Research and development expenses  $–   $11,433 
General and administrative expenses   64,787    160,381 
   $64,787   $171,814 
Schedule of assumptions used
        
   Year Ended December 31, 
   2025   2024 
Weighted-average expected dividend yield (%)   –    – 
Weighted-average expected volatility (%)   109.51    111.50 
Weighted-average risk-free interest rate (%)   3.78    4.20 
Weighted-average expected life of option (years)   5.5    5.67 
Weighted-average exercise price ($)   2.17    4.07 
Schedule of non-vested options
        
   Number of
shares		   Weighted-
average
grant date
fair value		 
Balance as of January 1, 2025   32,083   $3.49 
Granted   10,000    1.78 
Forfeited   –    – 
Vested   (18,749)   (3.58)
Balance as of December 31, 2025   23,334   $2.69 
Share-Based Payment Arrangement, Option [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of option activity
                    
   Number of
shares		   Weighted-
average
exercise
price		   Weighted-
average
remaining
life
(years)		   Aggregate
intrinsic
value		 
Outstanding as of January 1, 2024   201,388   $36.46    7.69   $– 
Granted   30,000    4.07           
Expired   (32,535)   (61.90)          
Outstanding as of December 31, 2024   198,853   $27.41    4.28   $3,300 
Granted   10,000    2.17           
Expired   (93,231)   (36.45)          
Outstanding as of December 31, 2025   115,622   $17.95    7.01   $– 
                     
Vested or expected to vest as of December 31, 2025   115,622   $17.95    7.01   $– 
                     
Exercisable as of December 31, 2024   166,770   $31.84    3.28   $2,567 
Exercisable as of December 31, 2025   92,288   $21.57    6.49   $– 
Non Employee Stock Options [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of option activity
                
   Number of
shares		   Weighted-
average
exercise
price		   Weighted-
average
remaining
life
(years)		   Aggregate
intrinsic
value		 
Outstanding as of January 1, 2024   1,925   $115.99    0.91   $– 
Granted   –    –           
Expired   (1,672)   50.20           
Outstanding as of December 31, 2024   253    550.80    0.68    – 
Granted   –    –           
Expired   (253)   550.80           
Outstanding as of December 31, 2025   –   $–    –   $– 
                     
Vested or expected to vest as of December 31, 2025   –   $–    –   $– 
                     
Exercisable as of December 31, 2024   253   $550.80    0.68   $– 
Exercisable as of December 31, 2025   –   $–    –   $–